Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.

One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.

From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.

Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.